References
- Kirchner JA. Fifteenth Daniel C. Baker, Jr, memorial lecture. What have whole organ sections contributed to the treatment of laryngeal cancer?. Ann Otol Rhinol Laryngol 1989; 98: 661–7
- Leroux-Robert J. Les épitheliomas intra-laryngés. Formes anatomo-cliniques. Voies dèxtesion. Thése pour le doctorat en médicine. Gaston Doin & Cie, Paris 1936
- Kernan JD. The pathology of carcinoma of the larynx studied in serial sections. Trans Am Acad Ophthalmol Otolaryngol 1950; 55: 10–21
- Kirchner JA. Two hundred laryngeal cancers: patterns of growth and spread as seen in serial section. Laryngoscope 1977; 87(4 Pt1)474–82
- Eckel HE, Sittel C, Walger M, Sprinzl G, Koebke J. Plastination: a new approach to morphological research and instruction with excised larynges. Ann Otol Rhinol Laryngol 1993; 102: 660–5
- Eckel HE, Sittel C. Morphometry of the larynx in horizontal sections. Am J Otolaryngol 1995; 16: 40–8
- Sittel C, Eckel HE, Sprinzl GM, Stennert E. Plastination of the larynx for whole-organ sectioning. Eur Arch Otorhinolaryngol 1997; 254(Suppl 1)S93–S96
- van Diest PJ, Brugal G, Baak JPA. Proliferation markers in tumors: interpretation and clinical value. J Clin Pathol 1998; 51: 716–24
- Tubiana M, Courdi A. Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long term survival. Radiother Oncol 1989; 15: 1–18
- Spyratos F, Ferrero-Pous M, Trassard M, Hacene K, Phillips E, Tubiana-Hulin M, et al. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value. Cancer 2002; 94: 2151–9
- Pich A, Chiusa L, Navone R. Prognostic relevance of cell proliferation in head and neck tumors. Ann Oncol 2004; 15: 1319–29
- Tucker GF. A histological method for the study of the spread of carcinoma within the larynx. Ann Otol Rhinol Laryngol 1961; 70: 910–21
- Kirchner JA. One hundred laryngeal cancers studies by serial section. Ann Otol Rhinol Laryngol 1969; 78: 689–709
- Harrison DF. A long-term comparative study of the mammalian larynx, based on whole organ serial sectioning. Acta Otolaryngol (Stockh) 1976; 81: 167–72
- Veneroni S, Silvestrini R, Costa A, Salvatori P, Faranda A, Molinari R. Biological indicators of survival in patients treated by surgery for squamous cell carcinoma of the oral cavity and oropharynx. Oral Oncol 1997; 33: 408–13
- Nickels A, Bureik M, Montenarh M, Pfreundschuh M, Koch B. p53 antibodies: call for quality. Int J Cancer 1997; 73: 613–14
- Piffko J, Bankfalvi A, Ofner D, Kusch F, Bocker W, Joos U, et al. In situ assessment of cell proliferation at the invasive front of oral squamous cell carcinomas. Virchows Arch 1996; 429: 229–34
- Pich A, Chiusa L, Pisani P, Krengli M, Pia F, Navone R. Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma. J Cancer Res Clin Oncol 1992; 119: 106–10
- Kropveld A, Slootweg PJ, Blankenstein MA, Terhaard CH, Hordijk GJ. Ki-67 and p53 in T2 laryngeal cancer. Laryngoscope 1998; 108: 1548–52
- Jacob R, Welkoborsky HJ, Mann WJ, Hofken F, Dienes HP, Freije JE. Heterogeneity of squamous cell carcinomas of the head and neck –analysis of tumor biologic factors and proliferation rates. Laryngoscope 1996; 106(9 Pt1)1170–5